GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Other Current Receivables

Embecta (FRA:JX7) Other Current Receivables : €40 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Other Current Receivables?

Embecta's Other Current Receivables for the quarter that ended in Mar. 2024 was €40 Mil.

Embecta's quarterly Other Current Receivables declined from Sep. 2023 (€133.43 Mil) to Dec. 2023 (€101.15 Mil) but then stayed the same from Dec. 2023 (€101.15 Mil) to Mar. 2024 (€39.84 Mil).

Embecta's annual Other Current Receivables increased from Sep. 2021 (€0.00 Mil) to Sep. 2022 (€112.01 Mil) and increased from Sep. 2022 (€112.01 Mil) to Sep. 2023 (€133.43 Mil).


Embecta Other Current Receivables Historical Data

The historical data trend for Embecta's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Other Current Receivables Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
Other Current Receivables
- - - 112.01 133.43

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.78 155.99 133.43 101.15 39.84

Embecta Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Embecta Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Embecta's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta (FRA:JX7) Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines